2016
DOI: 10.3906/sag-1412-85
|View full text |Cite
|
Sign up to set email alerts
|

Proliferation and differentiation markers of colorectal adenocarcinomaand their correlation with clinicopathological factors

Abstract: Background/aim: The purpose of this study was to investigate proliferation and differentiation markers in colorectal adenocarcinoma and their correlation with clinicopathological factors.Materials and methods: Samples were collected from 38 patients with colorectal adenocarcinoma and 10 healthy controls. E-cadherin, carcinoembryonic antigen (mCEA), cyclin B1, vascular endothelial growth factor (VEGF), and erythropoietin (EPO) receptor (EPOR) were examined by immunohistochemistry; VEGF and EPO were examined by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 22 publications
0
2
0
2
Order By: Relevance
“…The circulating microRNAs markers miR-122 and miR-200 family members could be used in the development of a multi-marker blood test for colorectal cancer prognosis and survival[32]. The decreased erythropoietin expression, high vascular endothelial growth factor levels and elevated cyclin B1 expression, predominant moderate tumour differentiation, absence of metastasis, and negative lymph node status are reliable proliferation and differentiation markers indicating the low level of aggressiveness, better prognosis, and longer colorectal adenocarcinoma patient’s survival[33]. By means of solid-phase proximity ligation assay, 35 protein markers were simultaneously analyzed in a small amount of blood of stage I to IV colorectal cancer patients, however, these markers did not give better prognostic information than CEA[34].…”
Section: Discussionmentioning
confidence: 99%
“…The circulating microRNAs markers miR-122 and miR-200 family members could be used in the development of a multi-marker blood test for colorectal cancer prognosis and survival[32]. The decreased erythropoietin expression, high vascular endothelial growth factor levels and elevated cyclin B1 expression, predominant moderate tumour differentiation, absence of metastasis, and negative lymph node status are reliable proliferation and differentiation markers indicating the low level of aggressiveness, better prognosis, and longer colorectal adenocarcinoma patient’s survival[33]. By means of solid-phase proximity ligation assay, 35 protein markers were simultaneously analyzed in a small amount of blood of stage I to IV colorectal cancer patients, however, these markers did not give better prognostic information than CEA[34].…”
Section: Discussionmentioning
confidence: 99%
“…Faktori rizika koji se mogu promeniti uključuju alkohol, pušenje, gojaznost i neke lekove. Nepromenljivi faktori rizika uključuju pol, starost, dijabetes, te faktore koji se tiču samog tumora [29,30].…”
Section: Endoskopska Vakuum Terapija U Kolorektalnoj Hirurgijiunclassified
“…Jedna od novouvedenih metoda za lečenje komplikacije popuštanja anastomoze je endoskopska va-upotreba negativnog pritiska u terapiji rana use of negative pressure in wound therapy include alcohol, smoking, obesity, and some medications. Non-modifiable risk factors include sex, age, diabetes, and factors related to the tumor itself [29,30].…”
Section: Endoskopska Vakuum Terapija U Kolorektalnoj Hirurgijimentioning
confidence: 99%
“…Usvajanjem jednoobraznog uputstva za pripremu rada, povećao se broj mladih istraživača koji tokom stasavanja u poznate naučnike, pripremaju doktorske/magistarske teze [30], i objavljuju rukopise u prestižnim domaćim [31,32] ili svetskim časopisima [33][34][35][36]. Obaveza svakog istraživača, je da deluje u skladu sa etičkim normama naučno-istraživačkog kodeksa, i da učestvuje u otkrivanju i suzbijanju svakog oblika devijantnog ponašanja.…”
Section: Diskusija I Zaključakunclassified